Liječenje malignog mezotelioma poplućnice
2009
Aim: To evaluate the effect of chemotherapy in treatment of patients
with malignant pleural mesothelioma. Methods: The effectiveness of
chemotherapy was evaluated in 29 patients with malignant pleural
mesothelioma (MPM). The patients were treated in Clinical Hospital
Split, University Hospital for Lung Diseases, between the years
2002-2005. 24/29 patients (82.7 %) were occupationally exposed to
asbestos. Chemotherapy was applied after determination of MPM subtype
by pathohystological immunohystochemistry. Results: Epitheloid
mesothelioma was determined in 23/29 (79.3 %) patients. Results of
treatment were analyzed separately in 6 patients treated with
gemcitabine/cisplatine (PG protocol) in first line therapy, in 9
patients treated with epirubicine/mitomycine (EM protocol) in first
line therapy, and in 14 patients who refused chemotherapy and were on
supportive therapy. In accordance with WHO recommendations the
evaluation of chemotherapy effectiveness by response rate (RR) and mean
survival curve (MS) was done. RR was 33% in both groups: those on PG
and EM protocol, but MS was significantly better in patients treated
with EM protocol in the first line chemotherapy comparing to PG
protocol and supportive care. Conclusions: The EM protocol has better
MS results then PG protocol treatment. However, this study have
confirmed the chemo resistance of the tumor, low response rate to the
chemotherapy (only 10-30 %), without significant influence to MS.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
22
References
0
Citations
NaN
KQI